JP2014505012A5 - - Google Patents

Download PDF

Info

Publication number
JP2014505012A5
JP2014505012A5 JP2013535058A JP2013535058A JP2014505012A5 JP 2014505012 A5 JP2014505012 A5 JP 2014505012A5 JP 2013535058 A JP2013535058 A JP 2013535058A JP 2013535058 A JP2013535058 A JP 2013535058A JP 2014505012 A5 JP2014505012 A5 JP 2014505012A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
amino acid
acid sequence
seq
cell culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013535058A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014505012A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/056966 external-priority patent/WO2012054654A2/en
Publication of JP2014505012A publication Critical patent/JP2014505012A/ja
Publication of JP2014505012A5 publication Critical patent/JP2014505012A5/ja
Pending legal-status Critical Current

Links

JP2013535058A 2010-10-20 2011-10-19 抗葉酸受容体アルファ抗体の糖型 Pending JP2014505012A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39481210P 2010-10-20 2010-10-20
US61/394,812 2010-10-20
PCT/US2011/056966 WO2012054654A2 (en) 2010-10-20 2011-10-19 Anti-folate receptor alpha antibody glycoforms

Publications (2)

Publication Number Publication Date
JP2014505012A JP2014505012A (ja) 2014-02-27
JP2014505012A5 true JP2014505012A5 (cg-RX-API-DMAC7.html) 2014-12-04

Family

ID=45975873

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013535058A Pending JP2014505012A (ja) 2010-10-20 2011-10-19 抗葉酸受容体アルファ抗体の糖型

Country Status (12)

Country Link
US (1) US20120164137A1 (cg-RX-API-DMAC7.html)
EP (1) EP2629798A4 (cg-RX-API-DMAC7.html)
JP (1) JP2014505012A (cg-RX-API-DMAC7.html)
KR (1) KR20140032944A (cg-RX-API-DMAC7.html)
CN (1) CN103347537A (cg-RX-API-DMAC7.html)
AU (2) AU2011317088B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013009275A2 (cg-RX-API-DMAC7.html)
CA (1) CA2815080A1 (cg-RX-API-DMAC7.html)
IL (1) IL225579A0 (cg-RX-API-DMAC7.html)
MX (1) MX2013004202A (cg-RX-API-DMAC7.html)
RU (1) RU2013122843A (cg-RX-API-DMAC7.html)
WO (1) WO2012054654A2 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2172487A1 (en) * 2005-04-22 2010-04-07 Morphotek Inc. Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells
JP6122948B2 (ja) 2012-05-15 2017-04-26 モルフォテック, インコーポレイテッド 胃癌の治療のための方法
SG11201500938XA (en) * 2012-08-31 2015-04-29 Immunogen Inc Diagnostic assays and kits for detection of folate receptor 1
CN104884617B (zh) 2012-12-07 2019-02-19 协和发酵麒麟株式会社 抗folr1抗体
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
TWI771890B (zh) 2013-03-14 2022-07-21 美商安美基公司 用於增加重組蛋白質之甘露糖含量之方法
US9677105B2 (en) 2013-03-14 2017-06-13 Momenta Pharmaceuticals, Inc. Methods of cell culture
US20140271622A1 (en) * 2013-03-14 2014-09-18 Momenta Pharmaceuticals, Inc. Methods of cell culture
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
NZ717140A (en) 2013-08-30 2022-05-27 Immunogen Inc Antibodies and assays for detection of folate receptor 1
EP2871190A1 (en) * 2013-11-11 2015-05-13 ATLAB Pharma Antibody against GD2-O-acetylated ganglioside with pro-apoptotic activity
ES2808853T3 (es) 2014-11-20 2021-03-02 Hoffmann La Roche Cadenas ligeras comunes y procedimientos de uso
RS61010B1 (sr) 2014-11-20 2020-11-30 Hoffmann La Roche Bispecifični antigen vezujući molekuli koji aktiviraju t ćelije protiv folr1 i cd3
SG11201704056XA (en) 2014-11-20 2017-06-29 Hoffmann La Roche Combination therapy of t cell activating bispecific antigen binding molecules cd3 abd folate receptor 1 (folr1) and pd-1 axis binding antagonists
CA2969225C (en) * 2014-12-01 2023-08-22 Amgen Inc. Process for manipulating the level of glycan content of a glycoprotein
CN122075735A (zh) 2015-09-17 2026-05-26 伊缪诺金公司 包含抗folr1免疫缀合物的治疗组合
EP3765521A4 (en) 2018-03-13 2022-03-23 Phanes Therapeutics, Inc. ANTI-FOLATE RECEPTOR-1 ANTIBODIES AND USES THEREOF
KR102275930B1 (ko) * 2018-03-14 2021-07-12 (주)알테오젠 Folr1에 특이적으로 결합하는 항체 및 그의 용도
CN118344485B (zh) * 2024-06-18 2024-10-15 南京欧凯生物科技有限公司 抗叶酸及其结合蛋白复合物的单克隆抗体或其抗原结合片段、其制备方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050054048A1 (en) * 2003-07-29 2005-03-10 Luigi Grasso Antibodies and methods for generating genetically altered antibodies with enhanced effector function
CA2556027C (en) * 2004-02-12 2015-11-24 Morphotek, Inc. Monoclonal antibodies that specifically block biological activity of a tumor antigen
BRPI0514068B8 (pt) * 2004-08-04 2021-05-25 Applied Molecular Evolution Inc anticorpo anti-cd20, e, composição farmacêutica
CN101374545B (zh) * 2005-04-15 2012-03-28 免疫基因公司 消除肿瘤中的异质或混合细胞群体
EP2172487A1 (en) * 2005-04-22 2010-04-07 Morphotek Inc. Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells
CN105709237A (zh) * 2005-12-16 2016-06-29 Ibc 医药公司 基于免疫球蛋白的多价生物活性装配体
WO2011116387A1 (en) * 2010-03-19 2011-09-22 Tetragenetics, Inc. Production of aglycosylated monoclonal antibodies in ciliates

Similar Documents

Publication Publication Date Title
RU2013122843A (ru) Гликоформы антитела против фолатного рецептора альфа
RU2577226C2 (ru) Способ получения биспецифических антител против cd3*cd19 формата флексибоди в клетках млекопитающих
JP7280827B2 (ja) Axlまたはror2に対するキメラ抗原受容体およびその使用方法
CN107217042B (zh) 一种生产无岩藻糖基化蛋白的基因工程细胞系及其建立方法
CN105296433B (zh) 一种ctla4抗体、其药物组合物及其用途
TWI685503B (zh) 細胞傷害誘導治療劑
JP6412552B2 (ja) 酵母及び他の形質転換細胞中のポリペプチドの高収率発現のための温度シフト
JP7857221B2 (ja) 高度にシアリル化された多量体結合分子
CN111534475B (zh) 一种细胞表面偶联抗体的方法及其应用
KR20190134994A (ko) Muc1 및 cd3에 결합하는 다중특이적 항체 작제물
JP2002512014A5 (cg-RX-API-DMAC7.html)
EP3019528A1 (en) Improved process for production of monoclonal antibodies
CN106459185A (zh) 通过调节抗体的含糖量制备抗体的方法
CN104558192A (zh) 一种双特异性抗体her2xcd3的构建及应用
WO2015081389A1 (en) A method of treating neoplasia
CN121248787B (zh) 一种人源化抗人muc1单克隆抗体及其应用
CN118221811B (zh) 靶向prame多肽的单域抗体及其用途
CN119497718A (zh) 三特异性抗体及其用途
CN107840889A (zh) 高亲和力的抗cd123抗体及其应用
CN103012590B (zh) 一种抗cd20单克隆抗体及其制备方法和用途
CN114835810A (zh) 一种抗pd-1纳米抗体及其应用
CN104651314B (zh) 获得高产稳定表达细胞克隆的方法及由此获得的抗体分子
CN118165102B (zh) 靶向hbv全长包膜蛋白的单域抗体及其用途
CN107460221A (zh) 一种降低抗pd‑l1抗体中蛋白聚合物的细胞培养方法
CN105646704B (zh) 抗p185erbB2人鼠嵌合抗体ChAb26、乳腺特异性表达载体、转基因FVB小鼠及其制备方法